HOME >> BIOLOGY >> NEWS
Grant strengthens research arm of Penn State Hershey Medical Center's ALS Clinic

Penn State Hershey Medical Center researchers were recently awarded a $265,000 grant from the Muscular Dystrophy Association to study possible genetic mutation risk factors for Lou Gehrig's Disease, known medically as amyotrophic lateral sclerosis (ALS).

This three-year grant strengthens the research arm of the Medical Center's ALS clinic, one of the largest treatment centers for the disease in Pennsylvania. ALS is a neurodegenerative disease that starts with muscle weakness and progresses to loss of muscle function and death. There is no known cause of the disease and no known treatment.

PGA golfer Tom Watson and his caddie, Bruce Edwards, recently have brought a great deal of attention to the disease since Edwards' diagnosis in January 2003. About 30,000 people in the U.S. live with ALS and sufferers usually survive five years or less after diagnosis. "Because so little it known about ALS, a number of our families from the clinic have been working with us to raise funds to support ALS research," said Zachary Simmons, M.D., professor and interim chair, Department of Neurology, and director of the ALS Clinic at Penn State Hershey Medical Center. "This award makes it possible for us to look into possible causes and risk factors of ALS and add to what little information is known about this disease."

In a preliminary study of 74 people diagnosed with ALS, Simmons and research partner James R. Connor, Ph.D., professor of neural and behavioral sciences, Penn State College of Medicine, found that there is a high prevalence of a mutation in a gene called Hfe in ALS patients.

"This suggests that the Hfe mutation is a risk factor for ALS," Connor said. "This grant will allow us to expand the number of individuals we can test with and without diagnosed ALS and continue our studies to see how the mutation affects onset and progression of this disease."

For the study, Connor and Simmons will identify patients with ALS and those with other neuromuscu
'"/>

Contact: Valerie Gliem
vgliem@psu.edu
814-865-9481
Penn State
28-Jul-2003


Page: 1 2

Related biology news :

1. Grant advances biochemical engineering laboratory
2. GlaxoSmithKline Drug Discovery and Development Research Grant Program 2004
3. Grant from GE Foundation to University of Houston to strengthen math, tech pipeline
4. McGill Centre for Intellectual Property Policy receives $3 million SSHRC Grant
5. Grant promotes marine ornamental fish aquaculture
6. Grant of powerful computer to Rutgers-Newark will increase understanding of brain activity
7. Grant renews funding of research toward cloning primates
8. Lipids get the spotlight in new NIGMS Glue Grant
9. Grant funds research to develop tissue-engineered solutions for heart disease
10. Sea Grant News & Notes for March 26, 2003
11. Grant funds research to develop microbicide barrier to HIV

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/21/2019)... ... August 20, 2019 , ... ... bioactive technologies for the spine, today announced the 510(K) clearance of its novel ... modification that is proven to improve osseointegration through superior hydrophilicity and optimized surface ...
(Date:8/19/2019)... ... August 19, 2019 , ... Since ... use of ultra-thin two dimensional slices which are placed on microscope slides, stained ... complex tissues and complicated features such as vasculature and thus researchers in the ...
(Date:8/15/2019)... , ... August 15, 2019 , ... ... Now what? As serialization mandates become increasingly complex, and aggregation becomes fully applied ... serialization software is the best long-term solution. , Until now, most regulations?including the ...
Breaking Biology News(10 mins):
(Date:6/26/2019)... ... June 26, 2019 , ... Alice Branton today released research results from ... of Magnesium Gluconate, which can prove to be beneficial for treating Hypomagnesemia. , The ... peak, change in crystallite size , Over 142% increase in particle size ...
(Date:6/18/2019)... , ... June 18, 2019 , ... Personalized Stem ... New Drug (IND) application to the FDA for use of a person’s own adipose-derived ... a treatment of osteoarthritis in the knee. This IND is the first of ...
(Date:6/11/2019)... MONTREAL (PRWEB) , ... June 10, 2019 , ... ... growth of its distribution network with the appointment of Biofeedback Tech Ltd ... physiological monitoring systems are an essential part of many therapeutic treatments and clinical ...
(Date:6/11/2019)... ... June 10, 2019 , ... DeepDyve ... its scientific journals to DeepDyve’s rental service for peer-reviewed journals. , IOPP’s ... of more than 20 million articles, sourced from more than 15,000 journals. , ...
Breaking Biology Technology:
Cached News: